Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion: ‘symptomatic control’

The treatment of brainstem metastases remains a challenge as the brainstem itself is considered a neurological organ at risk. We aimed to investigate the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy (HFSRT) for brainstem metastases, and to examine the balance between...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Masaki, Nishimura, Hideki, Mayahara, Hiroshi, Uezono, Haruka, Harada, Aya, Hashimoto, Naoki, Ejima, Yasuo, Ishihara, Takeaki, Nishikawa, Ryo, Sasaki, Ryohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710515/
https://www.ncbi.nlm.nih.gov/pubmed/28992239
http://dx.doi.org/10.1093/jrr/rrx042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710515/
https://www.ncbi.nlm.nih.gov/pubmed/28992239
http://dx.doi.org/10.1093/jrr/rrx042

Ejemplares similares